Impact of the COVID-19 pandemic on the occurrence and outcome
of cardiogenic shock complicating acute myocardial infarction

J 2023

Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

MOTOVSKA, Zuzana, Ota HLINOMAZ, Jan MROZEK, Petr KALA, Jiří JARKOVSKÝ et. al.

Basic information

Original name

Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

Authors

MOTOVSKA, Zuzana (203 Czech Republic), Ota HLINOMAZ (203 Czech Republic, belonging to the institution), Jan MROZEK (203 Czech Republic), Petr KALA (203 Czech Republic, belonging to the institution) and Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution)

Edition

European Journal of Internal Medicine, AMSTERDAM, ELSEVIER, 2023, 0953-6205

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 8.000 in 2022

RIV identification code

RIV/00216224:14110/23:00133064

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.ejim.2023.05.032

UT WoS

001073531600001

Keywords in English

cardiogenic shock; acute myocardial infarction; COVID-19

Abstract

V originále

SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease .

Links

LX22NPO5104, research and development project

Name: Národní institut pro výzkum metabolických a kardiovaskulárních onemocnění (Acronym: CarDia)

Investor: Ministry of Education, Youth and Sports of the CR, 5.1 EXCELES

NV19-02-00086, research and development project

Name: Duální protidestičková léčba pacientů s akutním infarktem myokardu v kardiogenním šoku - studie DAPT-SHOCK AMI

Investor: Ministry of Health of the CR

90249, large research infrastructures

Name: CZECRIN IV

Citovat

MOTOVSKA, Zuzana, Ota HLINOMAZ, Jan MROZEK, Petr KALA and Jiří JARKOVSKÝ. Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction. European Journal of Internal Medicine. AMSTERDAM: ELSEVIER, 2023, vol. 115, September 2023, p. 134-136. ISSN 0953-6205. Available from: https://dx.doi.org/10.1016/j.ejim.2023.05.032.

@article{2362117,
   author = {Motovska, Zuzana and Hlinomaz, Ota and Mrozek, Jan and Kala, Petr and Jarkovský, Jiří},
   article_location = {AMSTERDAM},
   article_number = {September 2023},
   doi = {http://dx.doi.org/10.1016/j.ejim.2023.05.032},
   keywords = {cardiogenic shock; acute myocardial infarction; COVID-19},
   language = {eng},
   issn = {0953-6205},
   journal = {European Journal of Internal Medicine},
   title = {Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction},
   url = {https://www.sciencedirect.com/science/article/pii/S095362052300184X?via%3Dihub},
   volume = {115},
   year = {2023}
}

TY  - JOUR
ID  - 2362117
AU  - Motovska, Zuzana - Hlinomaz, Ota - Mrozek, Jan - Kala, Petr - Jarkovský, Jiří
PY  - 2023
TI  - Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction
JF  - European Journal of Internal Medicine
VL  - 115
IS  - September 2023
SP  - 134-136
EP  - 134-136
PB  - ELSEVIER
SN  - 09536205
KW  - cardiogenic shock
KW  - acute myocardial infarction
KW  - COVID-19
UR  - https://www.sciencedirect.com/science/article/pii/S095362052300184X?via%3Dihub
N2  - SARS-CoV-2 predisposes patients to thrombotic disease due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. The infection was recognized as an independent risk factor for acute myocardial infarction (AMI), which is considered part of the clinical picture of the COVID-19 disease. Cardiovascular disease increases both the susceptibility to SARS-COV-2 and the risk of death in patients with COVID-19. Among those who died and were COVID PCR-positive, almost one-third (30%) suffered from ischemic heart disease .
ER  -

MOTOVSKA, Zuzana, Ota HLINOMAZ, Jan MROZEK, Petr KALA and Jiří JARKOVSKÝ. Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction. \textit{European Journal of Internal Medicine}. AMSTERDAM: ELSEVIER, 2023, vol.~115, September 2023, p.~134-136. ISSN~0953-6205. Available from: https://dx.doi.org/10.1016/j.ejim.2023.05.032.

Detailed Information on Publication Record